Company / Current Liabilities
Insulet Corporation Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$680.1M
FY2025
5-year range
$228.8M / $680.1M
FY2021-FY2025
Trend
+28.7%
vs FY2024
Sector context
#65 of 165
Health Care
What the data says
At $680M, Insulet Corporation's current liabilities ranks #101 of 165 in the Health Care sector. Current Liabilities has increased for 9 consecutive years, from $56M in FY2016 to $680M in FY2025.
Based on SEC 10-K filings.
$680M in FY2025 with a 5-year CAGR of +26.8%.
Increased from $451M to $680M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +23.1%
- 5-Year CAGR
- +26.8%
- 10-Year CAGR
- -
Sector benchmark
#101 of 165 in Health CareTop 61% of 165This company $680.1M Sector average $4.4B
▼
-84.7% below sector average
Key checks
Key Insights
- Insulet Corporation's current liabilities has grown for 9 consecutive years.
- 5-year CAGR of +26.8%, indicating consistent growth.
- In FY2025, current liabilities increased 28.7% year-over-year.
- Ranks #65 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $680.1M | +28.7% |
| FY2024 | $528.4M | +17.1% |
| FY2023 | $451.2M | +23.7% |
| FY2022 | $364.7M | +59.4% |
| FY2021 | $228.8M | +10.1% |
| FY2020 | $207.8M | +31.8% |
| FY2019 | $157.7M | +36.3% |
| FY2018 | $115.7M | +34.5% |
| FY2017 | $86.0M | +54.5% |
| FY2016 | $55.7M | -14.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026